Reckitt At '2.0' On Consumer Expansion But Question No. 1 Remains, Potential Pfizer Business Bid?
This article was originally published in The Pink Sheet
Executive Summary
UK firm sees acquisitions of Mead Johnson Nutrition and the Schiff brand as major milestones in its trajectory as a consumer health market competitor, but market analysts say both would be rendered comparatively minor moves if it makes an offer to acquire Pfizer's consumer products business.
You may also be interested in...
Pfizer Mum On Consumer Business Plans As Analysts Say Spin-off
Pfizer continues to review options for its consumer business, though analysts say a spin-off makes most sense. During its fourth-quarter earnings call, firm reported the division's US sales slumped 9% but 12% growth in international markets buoyed the worldwide results.
Schiff Supplements, MJN Formulas, Other Reckitt Benckiser Consumer Brands Get Their Own Home
UK manufacturer in January begins operating with a separate health care division, representing 60% of sales with products including Schiff supplements and Mead Johnson infant and adult formulas, and a home care/hygiene division led by Lysol disinfectants. The plan piques analysts' expectations that operating the divisions separately will lead to divesting one.
RB Says Petya Cyberattack Froze Shipments, Could Cost £100M
Beiersdorf and Merck also were impacted by the June 27 malware attack that rocked the globe, but RB's the only one of the three that's in any way quantified the hit it sustained. The blow comes at an unfortunate time for the UK-based company, whose first-quarter performance was its weakest in 15 years.